BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yoshimizu S, Yoshio T, Ishiyama A, Tsuchida T, Horiuchi Y, Omae M, Hirasawa T, Asari T, Chin K, Fujisaki J. Long-term outcomes of combined endoscopic resection and chemoradiotherapy for esophageal squamous cell carcinoma with submucosal invasion. Dig Liver Dis 2018;50:833-8. [PMID: 29477349 DOI: 10.1016/j.dld.2018.01.138] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 4.4] [Reference Citation Analysis]
Number Citing Articles
1 Zhang X, Wu H, Niu J, Hu Y, Zhang W, Chang J, Li L, Zhu J, Zhang C, Liu M. A Novel Mitochondria-Related Gene Signature in Esophageal Carcinoma: Prognostic, Immune, and Therapeutic Features.. [DOI: 10.21203/rs.3.rs-2456179/v1] [Reference Citation Analysis]
2 Suzuki G, Yamazaki H, Aibe N, Masui K, Kimoto T, Nagasawa S, Watanabe S, Seri S, Asato A, Shiozaki A, Fujiwara H, Konishi H, Dohi O, Ishikawa T, Elsaleh H, Yamada K. Chemoradiation versus surgery for superficial esophageal squamous cell carcinoma after noncurative endoscopic submucosal dissection: comparison of long-term oncologic outcomes. Radiat Oncol 2022;17:191. [DOI: 10.1186/s13014-022-02162-8] [Reference Citation Analysis]
3 Hatta W, Koike T, Uno K, Asano N, Masamune A. Management of Superficial Esophageal Squamous Cell Carcinoma and Early Gastric Cancer following Non-Curative Endoscopic Resection. Cancers 2022;14:3757. [DOI: 10.3390/cancers14153757] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Lyu B, Yin Y, Zhao Y, Yang X, Gong J, Zhang M, Chai G, Li Z, Shi M, Hui Z, Zhao L. Long-Term Clinical Outcomes and Safety Analysis of Superficial Esophageal Cancer Patients Treated with Definitive or Adjuvant Radiotherapy. Cancers 2022;14:3423. [DOI: 10.3390/cancers14143423] [Reference Citation Analysis]
5 Pimentel-Nunes P, Libânio D, Bastiaansen BAJ, Bhandari P, Bisschops R, Bourke MJ, Esposito G, Lemmers A, Maselli R, Messmann H, Pech O, Pioche M, Vieth M, Weusten BLAM, van Hooft JE, Deprez PH, Dinis-Ribeiro M. Endoscopic submucosal dissection for superficial gastrointestinal lesions: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - Update 2022. Endoscopy 2022;54:591-622. [PMID: 35523224 DOI: 10.1055/a-1811-7025] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 14.0] [Reference Citation Analysis]
6 Li J, Shen L, Liu F. Chemoradiotherapy for T1bN0M0 Esophageal Squamous Cell Carcinoma: A Practical Dilemma Delimited by Invasion Depth. Gastroenterology 2022;162:2129-30. [PMID: 34563473 DOI: 10.1053/j.gastro.2021.09.037] [Reference Citation Analysis]
7 Naito S, Yoshio T, Ishiyama A, Tsuchida T, Tokura J, Namikawa K, Tokai Y, Yoshimizu S, Horiuchi Y, Hirasawa T, Asari T, Mine S, Watanabe M, Ogura M, Chin K, Fukuzawa M, Itoi T, Fujisaki J. Long-term outcomes of esophageal squamous cell carcinoma with invasion depth of pathological T1a-muscularis mucosae and T1b-submucosa by endoscopic resection followed by appropriate additional treatment. Dig Endosc 2022;34:793-804. [PMID: 34599604 DOI: 10.1111/den.14154] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
8 Flor de Lima M, Castro B, Rodríguez-Carrasco M, Libânio D, Pimentel-Nunes P, Sousa O, Dinis-Ribeiro M. Best additional management after non-curative endoscopic resection of esophageal squamous cell carcinoma: a systematic review and meta-analysis. Scand J Gastroenterol 2022;57:525-33. [PMID: 34986068 DOI: 10.1080/00365521.2021.2023627] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Mei LX, Mo JX, Chen Y, Dai L, Wang YY, Chen MW. Esophagectomy versus definitive chemoradiotherapy as initial treatment for clinical stage I esophageal cancer: a systematic review and meta-analysis. Dis Esophagus 2022;35:doab049. [PMID: 34318324 DOI: 10.1093/dote/doab049] [Reference Citation Analysis]
10 Miyazaki T, Myojin M, Hosokawa M, Aoyama H, Okahara S, Takahashi H. Endoscopic resection as an independent predictive factor of local control in patients with T1bN0M0 esophageal squamous cell carcinoma treated with chemoradiotherapy: a retrospective study. Radiat Oncol 2022;17. [DOI: 10.1186/s13014-021-01972-6] [Reference Citation Analysis]
11 Wang CY, Chen BH, Lee CH, Le PH, Tsou YK, Lin CH. cT1N0M0 Esophageal Squamous Cell Carcinoma Invades the Muscularis Mucosa or Submucosa: Comparison of the Results of Endoscopic Submucosal Dissection and Esophagectomy. Cancers (Basel) 2022;14:424. [PMID: 35053586 DOI: 10.3390/cancers14020424] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
12 Kadota T, Sato D, Inaba A, Nishihara K, Takashima K, Nakajo K, Yukami H, Mishima S, Sawada K, Kotani D, Fujiwara H, Nakamura M, Hojo H, Yoda Y, Kojima T, Fujita T, Yano T. Long-term clinical outcomes of patients diagnosed with pT1a-muscularis mucosae with lymphovascular invasion or pT1b after endoscopic resection for cT1N0M0 esophageal squamous cell carcinoma. Esophagus 2022;19:153-62. [PMID: 34420139 DOI: 10.1007/s10388-021-00873-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
13 Yang X, Men Y, Wang J, Kang J, Sun X, Zhao M, Sun S, Yuan M, Bao Y, Ma Z, Wang G, Hui Z. Additional Radiotherapy With or Without Chemotherapy Following Endoscopic Resection for Stage I Esophageal Carcinoma: A Pilot Study. Technol Cancer Res Treat 2021;20:15330338211048051. [PMID: 34657505 DOI: 10.1177/15330338211048051] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
14 Namikawa K, Yoshio T, Yoshimizu S, Ishiyama A, Tsuchida T, Tokai Y, Horiuchi Y, Hirasawa T, Fujisaki J. Clinical outcomes of endoscopic resection of preoperatively diagnosed non-circumferential T1a-muscularis mucosae or T1b-submucosa 1 esophageal squamous cell carcinoma. Sci Rep 2021;11:6554. [PMID: 33753766 DOI: 10.1038/s41598-021-85572-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
15 Gao YP, Li L, Yan J, Hou XX, Jia YX, Chang ZW, Guan XY, Qin YR. Down-Regulation of CIDEA Promoted Tumor Growth and Contributed to Cisplatin Resistance by Regulating the JNK-p21/Bad Signaling Pathways in Esophageal Squamous Cell Carcinoma. Front Oncol 2020;10:627845. [PMID: 33614508 DOI: 10.3389/fonc.2020.627845] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
16 Ishihara R, Arima M, Iizuka T, Oyama T, Katada C, Kato M, Goda K, Goto O, Tanaka K, Yano T, Yoshinaga S, Muto M, Kawakubo H, Fujishiro M, Yoshida M, Fujimoto K, Tajiri H, Inoue H; Japan Gastroenterological Endoscopy Society Guidelines Committee of ESD/EMR for Esophageal Cancer. Endoscopic submucosal dissection/endoscopic mucosal resection guidelines for esophageal cancer. Dig Endosc 2020;32:452-93. [PMID: 32072683 DOI: 10.1111/den.13654] [Cited by in Crossref: 113] [Cited by in F6Publishing: 88] [Article Influence: 37.7] [Reference Citation Analysis]
17 Xu J, Wang G, Gong W, Guo S, Li D, Zhan Q. The noncoding function of NELFA mRNA promotes the development of oesophageal squamous cell carcinoma by regulating the Rad17-RFC2-5 complex. Mol Oncol 2020;14:611-24. [PMID: 31845510 DOI: 10.1002/1878-0261.12619] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
18 Tsou YK, Lee CH, Le PH, Chen BH. Adjuvant therapy for pT1a-m3/pT1b esophageal squamous cell carcinoma after endoscopic resection: Esophagectomy or chemoradiotherapy? A critical review. Crit Rev Oncol Hematol 2020;147:102883. [PMID: 32014674 DOI: 10.1016/j.critrevonc.2020.102883] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 5.7] [Reference Citation Analysis]
19 Minashi K, Nihei K, Mizusawa J, Takizawa K, Yano T, Ezoe Y, Tsuchida T, Ono H, Iizuka T, Hanaoka N, Oda I, Morita Y, Tajika M, Fujiwara J, Yamamoto Y, Katada C, Hori S, Doyama H, Oyama T, Nebiki H, Amagai K, Kubota Y, Nishimura K, Kobayashi N, Suzuki T, Hirasawa K, Takeuchi T, Fukuda H, Muto M. Efficacy of Endoscopic Resection and Selective Chemoradiotherapy for Stage I Esophageal Squamous Cell Carcinoma. Gastroenterology 2019;157:382-390.e3. [PMID: 31014996 DOI: 10.1053/j.gastro.2019.04.017] [Cited by in Crossref: 88] [Cited by in F6Publishing: 91] [Article Influence: 22.0] [Reference Citation Analysis]
20 Yoshimizu S, Yoshio T, Ishiyama A, Tsuchida T, Horiuchi Y, Omae M, Hirasawa T, Asari T, Chin K, Fujisaki J. Long-term outcomes of combined endoscopic resection and chemoradiotherapy for esophageal squamous cell carcinoma with submucosal invasion. Author's reply. Dig Liver Dis 2018;50:1255-6. [PMID: 30224315 DOI: 10.1016/j.dld.2018.07.044] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
21 Cisplatin/fluorouracil. Reactions Weekly 2018;1715:65-65. [DOI: 10.1007/s40278-018-50613-z] [Reference Citation Analysis]